Carr Financial Group’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.7K | Hold |
35,195
| – | – | 0.01% | 187 |
|
|
2025
Q1 | $28.4K | Hold |
35,195
| – | – | 0.01% | 175 |
|
|
2024
Q4 | $48.6K | Hold |
35,195
| – | – | 0.02% | 180 |
|
|
2024
Q3 | $36.6K | Hold |
35,195
| – | – | 0.01% | 194 |
|
|
2024
Q2 | $60.9K | Hold |
35,195
| – | – | 0.02% | 185 |
|
|
2024
Q1 | $84.1K | Hold |
35,195
| – | – | 0.03% | 178 |
|
|
2023
Q4 | $117K | Buy |
+35,195
| New | +$117K | 0.04% | 166 |
|